We conducted a nationwide cohort study of Chinese type 2 diabetic patients with an average follow-up period of 8.17 years to assess whether an elevated ALT level was associated with HCC independently of chronic liver diseases, and to demonstrate its interactive or joint effect with chronic liver diseases on HCC risk in type 2 diabetic patients. This evidence concerns the gene GPT and hepatocellular carcinoma.